Rossari Biotech Ltd - 543213 - Update On Investor Call.
Rossari Biotech informed that it would not be participating in the Nirmal Bang's Semi-Annual Investor Conference. The conference, an One-on-One & Group event, is scheduled for Monday, August 10, 2026.
Aug 06 2026 20:03:09
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Rossari Biotech Limited will participate in Nirmal Bang's Semi-Annual Investor Conference on August 10, 2026. The discussion will cover financial and other public information from the company's Earnings Presentation.
Aug 03 2026 19:56:23
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Rossari Biotech announced the audio recording of its Q1 FY27 earnings conference call, held with analysts and investors on July 20, 2026, is now available on the company website. This provides investors access to the call's discussions.
Jul 20 2026 21:25:47
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech announced Q1 FY27 consolidated revenue of Rs. 697.2 crore, marking a 28% YoY growth, alongside a 4% rise in PAT to Rs. 35.1 crore. The company also established a new greenfield blending facility in Thailand.
Jul 19 2026 16:28:05
Rossari Biotech Ltd - 543213 - Intimation Under Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015
Rossari Biotech's Board of Directors met on July 18, 2026, approving the unaudited financial results for Q1 FY27. Other key approvals included granting 4,000 employee stock options and transferring shareholding of an overseas subsidiary for internal group restructuring.
Jul 18 2026 17:02:06
Rossari Biotech Ltd - 543213 - Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 2019
Rossari Biotech's Board approved the transfer of 100% shareholding of Rossari International Limited Company (RILC) to Rossari (Singapore) Pte. Ltd. for Rs. 24 crore. This internal group restructuring aims to consolidate overseas subsidiaries under a single holding platform, with no expected material impact on consolidated financials.
Jul 18 2026 16:56:24
Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of Board Meeting Held On July 18, 2026.
Rossari Biotech's Board approved Q1 FY27 financial results. Consolidated revenue increased 28.2% YoY to ₹697.20 cr, and net profit rose 4.5% YoY to ₹35.10 cr. Standalone figures also saw significant growth.
Jul 18 2026 16:32:49
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Rossari Biotech announced an earnings conference call for investors and analysts on July 20, 2026, at 5:00 PM IST. The call will discuss Q1 FY27 financial results, which are expected to be declared on July 18, 2026.
Jul 14 2026 20:38:41
Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026
Rossari Biotech's Board of Directors will hold a meeting on July 18, 2026, to consider and approve the financial results for the quarter ended June 30, 2026. This is a routine update for the upcoming quarterly earnings announcement.
Jul 10 2026 22:42:22
Read More